A multiparametric organ toxicity predictor for drug discovery

Area of Science:

• Computational toxicology
• Drug discovery and development
• Pharmacokinetics and pharmacodynamics

Background:

• In silico predictive models are vital for assessing major organ toxicities in drug discovery.
• Computational tools leverage experimental data to predict chemical toxicities, significantly reducing compound attrition rates.
• The prediction of Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) endpoints for drug leads is widely accepted in academia and industry.

Purpose of the Study:

• To highlight the importance of in silico models in predicting drug-induced organ toxicities.
• To emphasize the role of computational tools in reducing drug discovery attrition rates.
• To discuss the integration of various molecular properties for enhanced toxicity prediction.

Main Methods:

• Utilizing multiparametric models incorporating physico-chemical properties, quantitative structure-activity relationship (QSAR) predictions, and docking scores.
• Employing advanced machine learning techniques, pharmacophore fingerprints, and toxicophores for toxicity prediction.
• Leveraging powerful biomarkers for accurate predictive scoring of drug adverse impacts on organs.

Main Results:

• Multiparametric models offer reliable prediction of chemical toxicities with atomic-level insights.
• In silico models guide decisions for in vitro and in vivo studies, confirming cytotoxicity, pharmacokinetic, and pharmacodynamic properties.
• Current computational tools can predict ADMET and organ toxicities effectively.

Conclusions:

• There is a critical need to integrate molecular properties for better toxicity prediction and drug optimization.
• In silico models provide informed decisions, enhancing the efficiency of drug discovery and development pipelines.
• Despite existing filters, drugs are still withdrawn; improved computational approaches are essential for identifying safer drug leads.